Market News AIOpen the app

GANX stock news · Gain Therapeutics, Inc.

Stories about Gain Therapeutics, Inc. (GANX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for GANX

Follow Gain Therapeutics, Inc. (GANX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GANX
Free on the App Store and Google Play, or on the web.
  1. Nov 10, 2026, 4:11 PM ET · Market

    Gain Therapeutics shared its financial results and business update for the third quarter of 2026.

    Neutral

    Gain Therapeutics announced its third-quarter results and a business update, but this filing gives no figures or details. It does not show a change in the company's outlook.

  2. Oct 1, 2026, 9:23 AM ET · Market

    Gain Therapeutics, Inc. shares news about new research on rexaceract for Parkinson's disease.

    Good for GANX

    Gain Therapeutics reported stable movement scores after 12 months of treatment and plans a Phase 2 trial. Early signs support its Parkinson's drug program but do not prove it works.